Overcoming limitations for antibody-based therapies targeting γδ T (Vg9Vd2) cells
Therapeutic strategies targeting non-adaptive immune cells are currently in clinical development. γδT cells are a small subtype of T cells (1-10% of total T cells) that mediate their effector function without the necessity of the antigen presenting mac…